{"example_id": "0954-00", "context": "An NMP (1 mL) solution of 5'-fluoro-N-(1-methyl-3-(pyridin-2-yl)-1H-pyrazol-4-yl)-[2,3'-bipyridine]-6-carboxamide (22.5 mg, 0.06 mmol), dimethylamine hydrochloride (5 eq.) and NaHCO3 (2 eq) was heated at 120-150\u00b0 C. for 11 days until 50% of desired product was formed, as monitored by LC-MS. Solvent.", "anaphor": "Solvent", "gold_antecedents": ["NMP (1 mL)"], "preceding_anaphors": []}
{"example_id": "1464-00", "context": "Compound 45 was synthesized from macrocycle C (100 mg, 0.143 mmol), p-tolyl isocyanate (19.1 mg, 0.143 mmol) and triethylamine (78 \u03bcL, 0.574 mmol) as a white solid (30 mg, 26.3%).", "anaphor": "a white solid (30 mg, 26.3%)", "gold_antecedents": ["macrocycle C (100 mg, 0.143 mmol)", "p-tolyl isocyanate (19.1 mg, 0.143 mmol)", "triethylamine (78 \u03bcL, 0.574 mmol)"], "preceding_anaphors": []}
{"example_id": "1031-00", "context": "Steps similar to those in example 24 were employed, ruthenium complex 1a (1.2 mg, 0.002 mmol) was used as catalyst.", "anaphor": "catalyst", "gold_antecedents": ["ruthenium complex 1a (1.2 mg, 0.002 mmol)"], "preceding_anaphors": []}
{"example_id": "0080-00", "context": "m. PREPARATION OF (S)-3-(3,5-DIFLUOROPHENYL)-N-((2R,6S,8AS,14AS,20S,23AS)-2,6-DIMETRYL-5,8,14,19,23-PENTAOXOOCTADECAHYDRO-1H,5H,14H,19H-PYRIDO[2,1-I]DIPYRROLO[2,1-C:2',1'-L][1]OXA[4,7,10,13]TETRAAZACYCLOHEXADECIN-20-YL)-2-(3-(4-(TRIFLUOROMETHOXY)PHENYL)UREIDO)PROPANAMIDE (COMPOUND 13). Compound 13 was synthesized from compound C (70 mg, 0.100 mmol), 1-isocyanato-4-(trifluoromethoxy)benzene (24.5 mg, 0.12 mmol) and triethylamine (66 \u03bcL, 0.482 mmol) following the general synthesis method as described herein above. Compound 13.", "anaphor": "Compound 13", "gold_antecedents": ["compound C (70 mg, 0.100 mmol)", "1-isocyanato-4-(trifluoromethoxy)benzene (24.5 mg, 0.12 mmol)", "triethylamine (66 \u03bcL, 0.482 mmol)"], "preceding_anaphors": []}
{"example_id": "1380-00", "context": "A solution of 2-(3-amino-4-(thiophen-3-yl)phenyl)-N-cyclopropyl-2,2-difluoroacetamide (50.0 mg, 0.16 mmol) and 3-(trifluoromethyl)phenyl isocyanate (35.5 mg, 0.19 mmol) in dichloromethane (50 mL) was stirred at room temperature for 12 hours. The reaction mixture.", "anaphor": "The reaction mixture", "gold_antecedents": ["A solution of 2-(3-amino-4-(thiophen-3-yl)phenyl)-N-cyclopropyl-2,2-difluoroacetamide (50.0 mg, 0.16 mmol) and 3-(trifluoromethyl)phenyl isocyanate (35.5 mg, 0.19 mmol) in dichloromethane (50 mL)"], "preceding_anaphors": []}
{"example_id": "1032-00", "context": "Isopropanol solution (20.03 g) containing (R)-3-aminoquinuclidine (5.05 g: 40.0 mmol) was charged into a 50 mL-flask equipped with a mechanical stirrer, a thermometer, and a cooling line.", "anaphor": "a 50 mL-flask equipped with a mechanical stirrer, a thermometer, and a cooling line", "gold_antecedents": ["Isopropanol solution (20.03 g) containing (R)-3-aminoquinuclidine (5.05 g: 40.0 mmol)"], "preceding_anaphors": []}
{"example_id": "1032-01", "context": "Isopropanol solution (20.03 g) containing (R)-3-aminoquinuclidine (5.05 g: 40.0 mmol) was charged into a 50 mL-flask equipped with a mechanical stirrer, a thermometer, and a cooling line, and isopropanol solution (24.87 g) containing benzoic acid (9.70 g: 79.4 mmol) was added thereto while stirring at room temperature. Precipitated crystals.", "anaphor": "Precipitated crystals", "gold_antecedents": ["Isopropanol solution (20.03 g) containing (R)-3-aminoquinuclidine (5.05 g: 40.0 mmol)", "isopropanol solution (24.87 g) containing benzoic acid (9.70 g: 79.4 mmol)"], "preceding_anaphors": ["a 50 mL-flask equipped with a mechanical stirrer, a thermometer, and a cooling line"]}
{"example_id": "1032-03", "context": "Isopropanol solution (20.03 g) containing (R)-3-aminoquinuclidine (5.05 g: 40.0 mmol) was charged into a 50 mL-flask equipped with a mechanical stirrer, a thermometer, and a cooling line, and isopropanol solution (24.87 g) containing benzoic acid (9.70 g: 79.4 mmol) was added thereto while stirring at room temperature. Precipitated crystals were filtered, and then dried under reduced pressure at 60\u00b0 C., to obtain (R)-3-aminoquinuclidine.dibenzoate (9.54 g: 25.8 mmol, yield=64%) as a white crystal.", "anaphor": "a white crystal", "gold_antecedents": ["Isopropanol solution (20.03 g) containing (R)-3-aminoquinuclidine (5.05 g: 40.0 mmol)", "isopropanol solution (24.87 g) containing benzoic acid (9.70 g: 79.4 mmol)"], "preceding_anaphors": ["a 50 mL-flask equipped with a mechanical stirrer, a thermometer, and a cooling line", "Precipitated crystals", "(R)-3-aminoquinuclidine.dibenzoate (9.54 g: 25.8 mmol, yield=64%)"]}
{"example_id": "0120-00", "context": "The product (1.65 g, yield: 67%) as a white solid.", "anaphor": "a white solid", "gold_antecedents": ["The product (1.65 g, yield: 67%)"], "preceding_anaphors": []}
{"example_id": "0120-01", "context": "The product (1.65 g, yield: 67%) as a white solid was obtained in accordance with the steps in Example 5, by using 1.45 g (7 mmol) L-phenylalanine isopropyl ester as Raw material 2.", "anaphor": "Raw material 2", "gold_antecedents": ["1.45 g (7 mmol) L-phenylalanine isopropyl ester"], "preceding_anaphors": ["a white solid"]}
{"example_id": "0278-00", "context": "Tert-butyl4-(8-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimid in-2-yl)amino)-6-methyl-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperidin-1-car boxylate (90 mg, 0.137 mmol)was dissolved in dichloromethane (10 mL), and trifluoroacetic acid (1 mL) was added. After stirring at room temperature for 12 h, TLC detection showed that the raw materials disappeared. Water (10 mL) was added, and phases.", "anaphor": "phases", "gold_antecedents": ["Tert-butyl4-(8-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimid in-2-yl)amino)-6-methyl-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperidin-1-car boxylate (90 mg, 0.137 mmol)", "dichloromethane (10 mL)", "trifluoroacetic acid (1 mL)", "Water (10 mL)"], "preceding_anaphors": []}
{"example_id": "0278-01", "context": "Tert-butyl4-(8-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimid in-2-yl)amino)-6-methyl-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperidin-1-car boxylate (90 mg, 0.137 mmol)was dissolved in dichloromethane (10 mL), and trifluoroacetic acid (1 mL) was added. After stirring at room temperature for 12 h, TLC detection showed that the raw materials disappeared. Water (10 mL) was added, and phases were separated. The water phase.", "anaphor": "The water phase", "gold_antecedents": ["Tert-butyl4-(8-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimid in-2-yl)amino)-6-methyl-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperidin-1-car boxylate (90 mg, 0.137 mmol)", "dichloromethane (10 mL)", "trifluoroacetic acid (1 mL)", "Water (10 mL)"], "preceding_anaphors": ["phases"]}
{"example_id": "0278-02", "context": "Tert-butyl4-(8-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimid in-2-yl)amino)-6-methyl-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperidin-1-car boxylate (90 mg, 0.137 mmol)was dissolved in dichloromethane (10 mL), and trifluoroacetic acid (1 mL) was added. After stirring at room temperature for 12 h, TLC detection showed that the raw materials disappeared. Water (10 mL) was added, and phases were separated. The water phase was extracted with dichloromethane (10 mL\u00d72). The organic phases.", "anaphor": "The organic phases", "gold_antecedents": ["Tert-butyl4-(8-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimid in-2-yl)amino)-6-methyl-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperidin-1-car boxylate (90 mg, 0.137 mmol)", "dichloromethane (10 mL)", "trifluoroacetic acid (1 mL)", "Water (10 mL)", "dichloromethane (10 mL\u00d72)"], "preceding_anaphors": ["phases", "The water phase"]}
{"example_id": "0278-03", "context": "Tert-butyl4-(8-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimid in-2-yl)amino)-6-methyl-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperidin-1-car boxylate (90 mg, 0.137 mmol)was dissolved in dichloromethane (10 mL), and trifluoroacetic acid (1 mL) was added. After stirring at room temperature for 12 h, TLC detection showed that the raw materials disappeared. Water (10 mL) was added, and phases were separated. The water phase was extracted with dichloromethane (10 mL\u00d72). The organic phases were combined, and dried with anhydrous sodium sulphate. The solvent.", "anaphor": "The solvent", "gold_antecedents": ["dichloromethane (10 mL\u00d72)"], "preceding_anaphors": ["phases", "The water phase", "The organic phases"]}
{"example_id": "0278-04", "context": "Tert-butyl4-(8-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimid in-2-yl)amino)-6-methyl-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperidin-1-car boxylate (90 mg, 0.137 mmol)was dissolved in dichloromethane (10 mL), and trifluoroacetic acid (1 mL) was added. After stirring at room temperature for 12 h, TLC detection showed that the raw materials disappeared. Water (10 mL) was added, and phases were separated. The water phase was extracted with dichloromethane (10 mL\u00d72). The organic phases were combined, and dried with anhydrous sodium sulphate. The solvent was removed by rotary evaporation. The crude product.", "anaphor": "The crude product", "gold_antecedents": ["Tert-butyl4-(8-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimid in-2-yl)amino)-6-methyl-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperidin-1-car boxylate (90 mg, 0.137 mmol)", "dichloromethane (10 mL)", "trifluoroacetic acid (1 mL)", "Water (10 mL)", "dichloromethane (10 mL\u00d72)", "anhydrous sodium sulphate"], "preceding_anaphors": ["phases", "The water phase", "The organic phases", "The solvent"]}
{"example_id": "0278-05", "context": "Tert-butyl4-(8-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimid in-2-yl)amino)-6-methyl-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperidin-1-car boxylate (90 mg, 0.137 mmol)was dissolved in dichloromethane (10 mL), and trifluoroacetic acid (1 mL) was added. After stirring at room temperature for 12 h, TLC detection showed that the raw materials disappeared. Water (10 mL) was added, and phases were separated. The water phase was extracted with dichloromethane (10 mL\u00d72). The organic phases were combined, and dried with anhydrous sodium sulphate. The solvent was removed by rotary evaporation. The crude product was purified by silica gel column chromatography (methanol: dichloromethane=1:50) to obtain the final product (50 mg, yield: 65.5%).", "anaphor": "the final product (50 mg, yield: 65.5%)", "gold_antecedents": ["Tert-butyl4-(8-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimid in-2-yl)amino)-6-methyl-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperidin-1-car boxylate (90 mg, 0.137 mmol)", "dichloromethane (10 mL)", "trifluoroacetic acid (1 mL)", "Water (10 mL)", "dichloromethane (10 mL\u00d72)", "anhydrous sodium sulphate", "silica gel", "methanol: dichloromethane=1:50"], "preceding_anaphors": ["phases", "The water phase", "The organic phases", "The solvent", "The crude product"]}
